Skip to main content

Table 1 Average weekly percent change in semaglutide search probability by year and country

From: Sweetening the deal: an infodemiological study of worldwide interest in semaglutide using Google Trends extended for health application programming interface

 Country

 Average Weekly Percentage Change (95% Confidence Interval)

 2019

 2020

 2021

 2022

 2023

 2019-2023

Australia

 − 0.01 (− 0.2 – 0.06)

0.7* (0.5–0.9)

3.7* (3.1–3.6)

1.3* (1.1–1.5)

0.8* (0.5–1.0)

1.2* (11–1.3)

Belgium

 − 0.1 (− 0.2–0.0)

 − 0.1 (− 0.2–0.0)

 − 0.1 (− 0.2–0.0)

1.3 (1.0–1.6)

0.7 (0.0–1.1)

0.6* (0.5–0.7)

Brazil

3.0* (2.7–3.4)

1.6* (1.6–1.7)

1.6* (1.6–1.7)

1.6* (1.5–1.7)

 − 0.4 (− 1.0–0.2)

1.6* (1.5–1.7)

Bulgaria

 − 0.3* (− 0.4– − 0.2)

 − 0.3* (− 0.4– − 0.1)

0.3* (0.2–0.4)

0.4* (0.2–0.5)

0.4* (0.2–0.5)

 − 0.0* (− 0.2– − 0.0)

Canada

1.6* (1.1–2.1)

0.8* (0.5–1.1)

1.8* (1.7–1.9)

1.8* (1.7–1.9)

1.8* (1.7–1.9)

1.5* (1.4–1.6)

Chile

 − 0.3* (− 0.4– − 0.2)

 − 0.3* (− 0.4– − 0.2)

0.7* (0.5–0.8)

1.6* (1.4–1.8)

 − 0.4 (− 1.0–0.2)

0.3* (0.2–0.4)

Denmark

0.0* (0.0–0.1)

0.0* (0.0–0.1)

0.0* (0.0–0.1)

1.4* (1.2–1.5)

0.2 (− 0.5–0.7)

0.4* (0.3–0.5)

Finland

0.2* (0.1–0.3)

0.2* (0.1–0.3)

0.2* (0.1–0.3)

2.6* (2.1–2.6)

 − 2.3* (− .2.7– − 1.7)

0.3* (0.2–0.4)

Germany

 − 0.0 (− 0.4–0.3)

1.0* (0.7–1.1)

1.0* (0.9–1.2)

2.3* (2.1–2.5)

3.3* (3.0–3.8)

1.4* (1.3–1.5)

Ireland

0.0 (− 0.0–0.1)

0.0 (− 0.0–0.1)

0.0 (− 0.0–0.1)

1.9* (1.7–2.0)

0.1 (− 0.5–0.6)

0.5* (0.4–0.5)

Israel

 − 0.5* (− 0.7– − 0.2)

0.1 (− 0.1–0.3)

0.1 (− 0.0–0.3)

 − 0.1 (− 0.2–0.1)

 − 0.1 (− 0.3–0.0)

 − 0.1* (− 0.1– − 0.0)

Netherlands

 − 0.2 (− 0.5–0.0)

0.2 (− 0.0–0.3)

0.4* (0.2–0.6)

1.4* (1.2–1.6)

1.9* (1.7–2.2)

0.7* (0.6–0.7)

Norway

 − 0.4* (− 0.6– − 0.2)

0.1 (− 0.0–0.3)

0.3* (0.2–0.5)

1.1* (1.0–1.2)

1.1* (1.0–1.3)

0.4* (0.3–0.5)

Poland

 − 0.1 (− 0.2–0.0)

 − 0.1 (− 0.1–0.0)

2.5* (2.4–2.7)

1.9* (1.7–2.1)

0.4* (0.1–0.7)

 − 0.1 (− 0.2–0.0)

Portugal

 − 0.4* (− 0.7– − 0.2)

 − 0.1 (− 0.3–0.0)

0.1 (− 0.1–0.2)

0.8* (0.6–1.0)

1.1* (0.9–1.4)

0.2* (0.1–2.7)

Romania

 − 0.0 (− 0.1–0.0)

 − 0.0 (− 0.1–0.0)

 − 0.0 (− 0.1–0.0)

1.2* (1.1–1.4)

 − 0.3 (− 0.8–0.2)

0.2* (0.1–0.3)

Saudi Arabia

 − 0.2* (− 0.2– − 0.1)

 − 0.2* (− 0.2– − 0.1)

 − 0.2* (− 0.2– − 0.1)

0.4* (0.3–0.4)

 − 0.5* (− 0.7– − 0.2)

0.0 (− 0.0–0.1)

Serbia

 − 0.1* (− 0.1– − 0.0)

 − 0.1* (− 0.1– − 0.0)

 − 0.1* (− 0.1– − 0.0)

0.5* (0.2–0.8)

 − 0.7* (− 1.3– − 0.3)

 − 0.1 (− 0.1– − 0.0)

South Africa

 − 0.1* (− 0.2– − 0.2)

 − 0.1* (− 0.2– − 0.2)

 − 0.1* (− 0.2– − 0.2)

1.7* (1.5–1.9)

0.8* (0.4–1.2)

0.4* (0.3–0.5)

Spain

 − 0.4* (− 0.7– − 0.2)

0.4* (0.2–0.6)

1.1* (0.9–1.3)

1.8* (1.7–2.0)

1.8* (1.7–2.0)

0.9* (0.8–0.9)

Sweden

0.1* (0.0–0.1)

0.1* (0.0–0.1)

0.1* (0.0–0.1)

1.8* (1.7–2.0)

1.0* (0.5–1.5)

0.6* (0.5–0.6)

Switzerland

 − 0.3* (− 0.5– − 0.2)

0.1 (− 0.1–0.2)

0.3* (0.2–0.4)

1.1* (1.0–1.2)

1.6* (1.4–1.9)

0.5* (0.4–0.5)

UAE

 − 0.6* (− 0.9– − 0.4)

 − 0.2* (− 0.4– − 0.0)

0.0 (− 0.1–0.2)

0.7* (0.6–0.9)

1.0* (0.8–1.3)

0.1* (0.1–.02)

UK

 − 0.0 (− 0.3–0.2)

1.0* (0.7–1.2)

1.8* (1.6–2.0)

2.5* (2.3–2.7)

3.5* (3.1–4.1)

1.6* (1.5–1.7)

USA

0.6* (0.4–0.7)

0.9* (0.7–1.0)

1.5* (1.3–1.8)

2.8* (2.6–3.0)

3.0* (2.8–3.2)

1.7* (1.6–1.7)

  1. *p < 0.05